abs39.txt	objective		recent	evidence	suggests	the	Î±2-adrenoreceptor	agonist	dexmedetomidinemay	promote	metastasis	of	cancer	cells	in	this	study	we	sought	to	evaluate	theimpact	dexmedetomidine	administration	on	survival	children	andadolescents	with	design	retrospective	chart	review	setting	comprehensive	center	patients	and	adolescents	who	had	undergone	cytoreductive	surgery	withhyperthermic	intraperitoneal	chemotherapy	for	peritoneal	carcinomatosis	intervention	intraoperative	and/or	early	postoperative	(within	24	hours	ofsurgery)	measurements	multivariable	cox	proportional	hazard	models	were	used	assessthe	association	between	progression	freesurvival	(pfs)	or	overall	(os)	main	results	ninety-three	identified	median	age	was	12	years	42%	female	35%	received	there	no	significantdifferences	baseline	perioperative	characteristics	patientswho	those	did	not	multivariableanalysis	associated	pfs(hr	=	1	20	95%	ci	[0	60-2	41]	p	606)	os	(hr	0	81	35-1	85]	611)	conclusion	hadundergone	a	major	oncologic	earlypostoperative
